Margery A Connelly

Title: Margery A Connelly: Innovator in Liver Disease Prediction

Introduction

Margery A Connelly is a notable inventor in the field of medical research, particularly focusing on liver disease. She has developed innovative methods to predict mortality from alcoholic hepatitis using advanced techniques in biosample analysis. Her work has significant implications for patient care and treatment strategies.

Latest Patents

Margery A Connelly holds a patent titled "Methods To Predict Liver Disease Mortality Using Lipoprotein Lp-Z." This patent describes methods for determining patient mortality from alcoholic hepatitis through NMR spectroscopy. Specifically, it outlines the determination of a Z index score based on the lipoprotein constituent LP-Z found in blood plasma and serum. Although she has 3 patents, her contributions to the field are noteworthy.

Career Highlights

Throughout her career, Margery has worked with reputable organizations such as Liposcience, Inc. and Beth Israel Deaconess Medical Center. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to significant advancements in liver disease research.

Collaborations

Margery has collaborated with esteemed colleagues, including Zhenghui Gordon Jiang and James D Otvos. These partnerships have enhanced her research and expanded the impact of her work in the medical community.

Conclusion

Margery A Connelly's innovative approaches to predicting liver disease mortality highlight her dedication to improving patient outcomes. Her work continues to influence the field of medical research and offers valuable insights into the complexities of liver health.